VC
ACLX

Vivo Capital’s Arcellx ACLX Stock Holding History

Vivo Capital’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-503,565
Closed -$18.1M – 48
2023
Q3 		$18.1M Buy
503,565
+69,780
+16% +$2.41M 1.98% 15
2023
Q2 		$13.7M Buy
433,785
+143,072
+49% +$5.47M 0.95% 17
2023
Q1 		$8.96M Buy
+290,713
New +$8.82M 0.62% 22

Other funds holding ACLX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vivo Capital's ACLX Position: Q4 2023 in Review

Vivo Capital sold out of Arcellx (ACLX) in Q4 2023, closing a stake of 503,565 shares — an estimated $18.1M sold.

Vivo Capital first reported a position in ACLX in Q1 2023 and held it in 3 quarters. The position peaked at $18.1M in Q3 2023. 156 funds tracked by Wall St. Rank hold ACLX as of Q4 2023.

  • Vivo Capital reported no remaining Arcellx position as of Q4 2023 after selling out during the quarter.
  • Vivo Capital sold 503,565 Arcellx shares in Q4 2023, an estimated $18.1M.
  • Vivo Capital first reported a position in Arcellx in Q1 2023 and held it in 3 quarters.
  • Vivo Capital's Arcellx position peaked at $18.1M in Q3 2023.
  • 156 funds tracked by Wall St. Rank held Arcellx as of Q4 2023.

Based on Vivo Capital's 13F filing for Q4 2023, filed 7 Feb 2024.